somatrogon-ghla

CHEBI:CHEBI_752490

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2644529
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_start_date
20230731
package_marketing_start_date
20230731
marketing_category
BLA
pharm_class
11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA]
labeler_name
Pfizer Laboratories Div Pfizer Inc
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
generic_name
somatrogon-ghla
brand_name
Ngenla
brand_name_base
Ngenla
product_ndc
0069-0520
application_number
BLA761184
spl_id
4777a006-e84b-4448-94d9-ade4dff2a1d6
active_ingredient_name
SOMATROGON
active_ingredient_strength
60 mg/1.2mL
package_ndc
0069-0520-02
package_description
1 CARTRIDGE in 1 CARTON (0069-0520-02) / 1.2 mL in 1 CARTRIDGE (0069-0520-01)
unii
6D848RA61B
spl_set_id
06dce529-b741-4a1b-8842-3ad77be6e308
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class